Rigel Pharmaceuticals (RIGL) Current Leases (2010 - 2026)
Rigel Pharmaceuticals' (RIGL) quarterly Current Leases came in at $636000.0 in Q1 2026, up 39.47% year-on-year from $456000.0 in Q1 2025, and up 3.58% quarter-over-quarter from $614000.0 in Q4 2025.
Rigel Pharmaceuticals (RIGL) Current Leases (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Current Leases history runs 15 years deep, the most recent figure standing at $636000.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 39.47% year-over-year to $636000.0 in Q1 2026; TTM through Mar 2026 was $636000.0, a 39.47% increase from a year earlier, with the FY2025 full-year figure at $614000.0, up 115.44% from the prior year.
- Current Leases improved to $636000.0 in Q1 2026 per RIGL's latest filing, from $614000.0 in the prior quarter.
- Across five years, Current Leases topped out at $8.3 million in Q1 2022 and bottomed at $285000.0 in Q4 2024.
- The 5-year median for Current Leases is $636000.0 (2026), against an average of $1.5 million.
- Across the five-year window, Current Leases plunged 94.59% in 2023 and surged 115.44% in 2025, its largest moves.
- Year by year, Current Leases stood at $1.1 million in 2022, then tumbled by 38.92% to $692000.0 in 2023, then sank by 58.82% to $285000.0 in 2024, then jumped by 115.44% to $614000.0 in 2025, then gained by 3.58% to $636000.0 in 2026.
- Per Business Quant, the three latest RIGL Current Leases figures stand at $636000.0 (Q1 2026), $614000.0 (Q4 2025), and $594000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Rigel Pharmaceuticals | 681.25 Mn | 534.56 Mn | 54.21 Mn | 636,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 636,000.00 |
| Dec 31, 2025 | 614,000.00 |
| Sep 30, 2025 | 594,000.00 |
| Jun 30, 2025 | 517,000.00 |
| Mar 31, 2025 | 456,000.00 |
| Dec 31, 2024 | 285,000.00 |
| Sep 30, 2024 | 466,000.00 |
| Jun 30, 2024 | 639,000.00 |
| Mar 31, 2024 | 709,000.00 |
| Dec 31, 2023 | 692,000.00 |
| Sep 30, 2023 | 673,000.00 |
| Jun 30, 2023 | 466,000.00 |
| Mar 31, 2023 | 449,000.00 |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 3.31 Mn |
| Jun 30, 2022 | 5.81 Mn |
| Mar 31, 2022 | 8.30 Mn |
| Dec 31, 2021 | 9.89 Mn |
| Sep 30, 2021 | 9.57 Mn |
| Jun 30, 2021 | 9.22 Mn |